Stockholm, SE Access Newswire November 17, 2026 Ab Sto Vico Nasdaq Vcre , a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, today announced that the company wi
Why Is VCRE (VCRE) Stock Down Today?
Updated Nov 22, 2026 5:33 AM ET ยท Prev Close $9.91
Session Regime & Catalyst Assessment
68% Signal ConvictionVCRE Pulling Back 5.09% on 0.67x Relative Volume
Vcre (Vcre) is pulling back 5.09% (-$0.50) to $9.41 on 0.67x average session volume. Relative to benchmarks, VCRE is lagging the S&P 500 by -1.45%. 14-day RSI stands at 41.9, keeping momentum in a bearish regime.
Stockholm, SE Access Newswire November 17, 2026 Ab Sto Vico Nasdaq Vcre , a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, today announced that the company wi
Price ($9.41) trades relative to 20-day SMA ($10.09) and 50-day SMA ($9.77).
Market & Sector Relative Strength
VCRE lagging the S&P 500 by -1.45%Options Flow & Execution Desk
Recent VCRE Catalyst Headlines
Verified WireStockholm, SE Access Newswire November 10, 2026 Ab Sto Vico Nasdaq Vcre , a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, today announced that the company wi
Nike downgraded, Circle Internet upgraded Wall Street's top analyst calls
Stockholm, SE Access Newswire November 5, 2026 Ab Sto Vico Nasdaq Vcre , a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 receptor agonists, today announced its financial result
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $10.09 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (VCRE)
MIXED MA TRENDAbout VCRE
Get Instant VCRE Catalyst Alerts
Receive an email alert when VCRE triggers an unusual volume breakout, options sweep, or rating shift.
VCRE Session & Catalyst FAQ
Why is VCRE stock down today?
Vcre (Vcre) is pulling back 5.09% (-$0.50) to $9.41 on 0.67x average session volume. Relative to benchmarks, VCRE is lagging the S&P 500 by -1.45%. 14-day RSI stands at 41.9, keeping momentum in a bearish regime.
Is VCRE stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.67x relative volume (low participation). Our multi-factor model currently rates VCRE as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the VCRE Buy or Sell Decision Brief โ
What is VCRE's intrinsic value and expected trading range?
At $9.41, VCRE's modeled 1-to-3 session range is $8.89 โ $9.93, with a key inflection level at $10.09 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the VCRE Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for VCRE?
RSI at 41.9 reflects soft below-midline momentum. VCRE trades at $9.41 relative to its 20-day SMA ($10.09) and 50-day SMA ($9.77), reflecting a mixed moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.